Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant

Página do item simplificado
dc.contributor.authorFernando, Rodrigo C. [UNIFESP]
dc.contributor.authorRizzatti, Edgar G.
dc.contributor.authorBraga, Walter M. T. [UNIFESP]
dc.contributor.authorSantos, Melina G.
dc.contributor.authorOliveira, Mariana B. de [UNIFESP]
dc.contributor.authorPestana, Jose O. M. [UNIFESP]
dc.contributor.authorBaiocchi, Otavio Carvalho Guimarães [UNIFESP]
dc.contributor.authorColleoni, Gisele W. B. [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionGrp Fleury
dc.date.accessioned2016-01-24T14:34:34Z
dc.date.available2016-01-24T14:34:34Z
dc.date.issued2013-10-01
dc.description.abstractThe aim of the present study was to determine whether there is an association between serum free light chains (sFLC) quantification and the development of post-transplant lymphoproliferative disorder (PTLD), using serum samples from a nested case control cohort of patients with renal transplant. Ten new cases of PTLD and 46 controls were enrolled. Additional comparison groups consisted of five human immunodeficiency virus (HIV)-infected individuals, five with untreated Hodgkin lymphoma and six normal individuals. Serum kappa and lambda FLC concentrations were measured by nephelometry and compared with reference ranges (normal and renal ranges). kappa and/or lambda were above the normal range in 90% of cases and in 65% of matched controls. There was no statistically significant difference between all groups, except for lambda FLC concentrations between cases of PTLD and normal individuals (p = 0.016). the kappa/lambda sFLC ratios of cases and controls were within the renal range and normal range. Our results suggest that sFLC are not useful to predict PTLD development in renal transplant recipients.en
dc.description.affiliationUniversidade Federal de São Paulo, UNIFESP, Disciplina Hematol & Hemoterapia, Dept Oncol Clin & Expt, São Paulo, Brazil
dc.description.affiliationGrp Fleury, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, UNIFESP, Hosp Rim & Hipertensao, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, UNIFESP, Disciplina Hematol & Hemoterapia, Dept Oncol Clin & Expt, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, UNIFESP, Hosp Rim & Hipertensao, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent2177-2180
dc.identifierhttp://dx.doi.org/10.3109/10428194.2013.764423
dc.identifier.citationLeukemia & Lymphoma. London: Informa Healthcare, v. 54, n. 10, p. 2177-2180, 2013.
dc.identifier.doi10.3109/10428194.2013.764423
dc.identifier.issn1042-8194
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/36864
dc.identifier.wosWOS:000324589800017
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.ispartofLeukemia & Lymphoma
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.rights.licensehttp://informahealthcare.com/userimages/ContentEditor/1255620309227/Copyright_And_Permissions.pdf
dc.subjectPTLDen
dc.subjectfree light chainsen
dc.subjectrenal transplanten
dc.subjectbiomarkeren
dc.titleSerum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplanten
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos